C-reactive protein (CRP) is an annular (ring-shaped), pentameric protein found in blood plasma, whose levels rise in response to inflammation. C - Reactive Protein Test(CRP) is the C- reactive protein (CRP) assay kit which is used for research and for diagnostic. It can detect the C-reactive protein in human serum and plasma samples.
Highlights
The global C-Reactive Protein Testing market was valued at US$ 687 million in 2022 and is anticipated to reach US$ 844.5 million by 2029, witnessing a CAGR of 3.5% during the forecast period 2023-2029. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The major players in global C-Reactive Protein Test (CRP) market include Beckman Coulter, Roche, Siemens Healthineers, etc. The top 3 players occupy about 55% shares of the global market. North America and Europe are main markets, they occupy about 75% of the global market. Immunoturbidimetric is the main type, with a share about 60%. Hospitals is the main application, which holds a share about 75%.
Report Scope
This report aims to provide a comprehensive presentation of the global market for C-Reactive Protein Testing, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding C-Reactive Protein Testing.
The C-Reactive Protein Testing market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global C-Reactive Protein Testing market comprehensively. Regional market sizes, concerning products by type, by application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the C-Reactive Protein Testing companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by type, by application, and by regions.
By Company
Roche
EMD Millipore
Life technologies
Randox
Quest Diagnostics
Abaxis
Segment by Type
ELISA
Immunoturbidimetric
Chemiluminesence Immunoassay(CLIA)
High-sensitivity C-reactive Protein (hsCRP) Assay
Segment by Application
Cardiovascular Diseases
Infections
Diseases of Immune System
Rheumatoid Arthritis
Cancers
Inflammatory Bowel Disease
Osteomyelitis
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of C-Reactive Protein Testing companies鈥� competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the key companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global C-Reactive Protein Testing Market Size Growth Rate by Type: 2018 VS 2022 VS 2029
1.2.2 ELISA
1.2.3 Immunoturbidimetric
1.2.4 Chemiluminesence Immunoassay(CLIA)
1.2.5 High-sensitivity C-reactive Protein (hsCRP) Assay
1.3 Market by Application
1.3.1 Global C-Reactive Protein Testing Market Growth by Application: 2018 VS 2022 VS 2029
1.3.2 Cardiovascular Diseases
1.3.3 Infections
1.3.4 Diseases of Immune System
1.3.5 Rheumatoid Arthritis
1.3.6 Cancers
1.3.7 Inflammatory Bowel Disease
1.3.8 Osteomyelitis
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global C-Reactive Protein Testing Market Perspective (2018-2029)
2.2 C-Reactive Protein Testing Growth Trends by Region
2.2.1 Global C-Reactive Protein Testing Market Size by Region: 2018 VS 2022 VS 2029
2.2.2 C-Reactive Protein Testing Historic Market Size by Region (2018-2023)
2.2.3 C-Reactive Protein Testing Forecasted Market Size by Region (2024-2029)
2.3 C-Reactive Protein Testing Market Dynamics
2.3.1 C-Reactive Protein Testing Industry Trends
2.3.2 C-Reactive Protein Testing Market Drivers
2.3.3 C-Reactive Protein Testing Market Challenges
2.3.4 C-Reactive Protein Testing Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top C-Reactive Protein Testing Players by Revenue
3.1.1 Global Top C-Reactive Protein Testing Players by Revenue (2018-2023)
3.1.2 Global C-Reactive Protein Testing Revenue Market Share by Players (2018-2023)
3.2 Global C-Reactive Protein Testing Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by C-Reactive Protein Testing Revenue
3.4 Global C-Reactive Protein Testing Market Concentration Ratio
3.4.1 Global C-Reactive Protein Testing Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by C-Reactive Protein Testing Revenue in 2022
3.5 C-Reactive Protein Testing Key Players Head office and Area Served
3.6 Key Players C-Reactive Protein Testing Product Solution and Service
3.7 Date of Enter into C-Reactive Protein Testing Market
3.8 Mergers & Acquisitions, Expansion Plans
4 C-Reactive Protein Testing Breakdown Data by Type
4.1 Global C-Reactive Protein Testing Historic Market Size by Type (2018-2023)
4.2 Global C-Reactive Protein Testing Forecasted Market Size by Type (2024-2029)
5 C-Reactive Protein Testing Breakdown Data by Application
5.1 Global C-Reactive Protein Testing Historic Market Size by Application (2018-2023)
5.2 Global C-Reactive Protein Testing Forecasted Market Size by Application (2024-2029)
6 North America
6.1 North America C-Reactive Protein Testing Market Size (2018-2029)
6.2 North America C-Reactive Protein Testing Market Growth Rate by Country: 2018 VS 2022 VS 2029
6.3 North America C-Reactive Protein Testing Market Size by Country (2018-2023)
6.4 North America C-Reactive Protein Testing Market Size by Country (2024-2029)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe C-Reactive Protein Testing Market Size (2018-2029)
7.2 Europe C-Reactive Protein Testing Market Growth Rate by Country: 2018 VS 2022 VS 2029
7.3 Europe C-Reactive Protein Testing Market Size by Country (2018-2023)
7.4 Europe C-Reactive Protein Testing Market Size by Country (2024-2029)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific C-Reactive Protein Testing Market Size (2018-2029)
8.2 Asia-Pacific C-Reactive Protein Testing Market Growth Rate by Region: 2018 VS 2022 VS 2029
8.3 Asia-Pacific C-Reactive Protein Testing Market Size by Region (2018-2023)
8.4 Asia-Pacific C-Reactive Protein Testing Market Size by Region (2024-2029)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America C-Reactive Protein Testing Market Size (2018-2029)
9.2 Latin America C-Reactive Protein Testing Market Growth Rate by Country: 2018 VS 2022 VS 2029
9.3 Latin America C-Reactive Protein Testing Market Size by Country (2018-2023)
9.4 Latin America C-Reactive Protein Testing Market Size by Country (2024-2029)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa C-Reactive Protein Testing Market Size (2018-2029)
10.2 Middle East & Africa C-Reactive Protein Testing Market Growth Rate by Country: 2018 VS 2022 VS 2029
10.3 Middle East & Africa C-Reactive Protein Testing Market Size by Country (2018-2023)
10.4 Middle East & Africa C-Reactive Protein Testing Market Size by Country (2024-2029)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Roche
11.1.1 Roche Company Detail
11.1.2 Roche Business Overview
11.1.3 Roche C-Reactive Protein Testing Introduction
11.1.4 Roche Revenue in C-Reactive Protein Testing Business (2018-2023)
11.1.5 Roche Recent Development
11.2 EMD Millipore
11.2.1 EMD Millipore Company Detail
11.2.2 EMD Millipore Business Overview
11.2.3 EMD Millipore C-Reactive Protein Testing Introduction
11.2.4 EMD Millipore Revenue in C-Reactive Protein Testing Business (2018-2023)
11.2.5 EMD Millipore Recent Development
11.3 Life technologies
11.3.1 Life technologies Company Detail
11.3.2 Life technologies Business Overview
11.3.3 Life technologies C-Reactive Protein Testing Introduction
11.3.4 Life technologies Revenue in C-Reactive Protein Testing Business (2018-2023)
11.3.5 Life technologies Recent Development
11.4 Randox
11.4.1 Randox Company Detail
11.4.2 Randox Business Overview
11.4.3 Randox C-Reactive Protein Testing Introduction
11.4.4 Randox Revenue in C-Reactive Protein Testing Business (2018-2023)
11.4.5 Randox Recent Development
11.5 Quest Diagnostics
11.5.1 Quest Diagnostics Company Detail
11.5.2 Quest Diagnostics Business Overview
11.5.3 Quest Diagnostics C-Reactive Protein Testing Introduction
11.5.4 Quest Diagnostics Revenue in C-Reactive Protein Testing Business (2018-2023)
11.5.5 Quest Diagnostics Recent Development
11.6 Abaxis
11.6.1 Abaxis Company Detail
11.6.2 Abaxis Business Overview
11.6.3 Abaxis C-Reactive Protein Testing Introduction
11.6.4 Abaxis Revenue in C-Reactive Protein Testing Business (2018-2023)
11.6.5 Abaxis Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Roche
EMD Millipore
Life technologies
Randox
Quest Diagnostics
Abaxis
听
听
*If Applicable.
